Pure Global AI
NCT06385587Not yet recruiting

Technology-based Symptom Monitoring Intervention for Locally Advanced Head and Neck Cancer Patients

Technology-based Symptom Monitoring Intervention for Locally Advanced Head and Neck Cancer Patients Initiating Chemoradiation: A Pilot Study
Aptar Digital HealthClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Head and Neck Cancer
Drug/Device/Intervention
Oleena
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Aptar Digital Health
Timeline & enrollment
Phase
N/A
Start date
May 03, 2024
End date
Sep 27, 2025
Enrollment
30 participants
Primary outcome

Users' satisfaction

Summary

The goal of this observational study is to assess the satisfaction and usability of an
 interactive and patient-centered mobile application (app), Oleena™, designed to assist head
 and neck cancer patients undergoing chemoradiation in managing common and distressing
 symptoms in real-time, as well as to assess the satisfaction and usability of the related HCP
 web portal. Additional secondary usage and clinical endpoints that would be used to assess
 intervention efficacy in future trials will be collected.

ICD-10 classifications
Malignant neoplasm of other and ill-defined sites: Head, face and neckMalignant neoplasm: Skin of scalp and neckMalignant neoplasm: Connective and soft tissue of head, face and neckCarcinoma in situ: Skin of scalp and neckSecondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06385587
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06385587 through Pure Global AI's free database. This phase not specified trial is sponsored by Aptar Digital Health and is currently Not yet recruiting. The study focuses on Head and Neck Cancer. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.